Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 07:17 am Sale |
2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Euclidean Capital LLC | 2,336,909 5.100% |
-118,290 (-4.82%) |
Filing History |
| 2022-02-14 06:51 am Sale |
2010-02-28 | 13G | PMV Pharmaceuticals, Inc. PMVP |
INTERWEST PARTNERS X LP | 3,249,544 7.200% |
-3,220,367 (-49.77%) |
Filing History |
| 2022-02-11 10:06 am Sale |
2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
AVORO CAPITAL ADVISORS LLC | 1,465,000 3.200% |
-885,267 (-37.67%) |
Filing History |
| 2022-02-10 08:32 am Purchase |
2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
The Vanguard Group | 2,647,946 5.840% |
2,647,946 (New Position) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
BLACKROCK INC BLK |
2,539,824 5.600% |
2,539,824 (New Position) |
Filing History |
| 2022-01-26 11:54 am Purchase |
2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
J P MORGAN CHASE & CO JPM |
3,166,450 6.900% |
3,166,450 (New Position) |
Filing History |
| 2022-01-19 3:43 pm Purchase |
2022-01-14 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Cowen Financial Products LLC | 2,300,000 5.070% |
2,300,000 (New Position) |
Filing History |
| 2021-10-18 3:50 pm Sale |
2021-10-15 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Euclidean Capital LLC | 2,455,199 5.400% |
-2,218,624 (-47.47%) |
Filing History |
| 2021-05-07 5:00 pm Purchase |
2021-04-28 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Euclidean Capital LLC | 4,673,823 10.400% |
494,407 (+11.83%) |
Filing History |
| 2021-02-16 4:00 pm Purchase |
2020-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Nextech V Oncology S.C.S. SICAV-SIF | 2,528,290 5.600% |
2,528,290 (New Position) |
Filing History |
| 2021-02-12 7:50 pm Sale |
2020-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
VIKING GLOBAL INVESTORS LP | 2,364,062 5.300% |
-277,778 (-10.51%) |
Filing History |
| 2021-02-12 4:00 pm Purchase |
2020-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Euclidean Capital LLC | 4,179,416 9.300% |
4,179,416 (New Position) |
Filing History |
| 2021-02-12 08:11 am Purchase |
2020-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
AVORO CAPITAL ADVISORS LLC | 2,350,267 5.300% |
2,350,267 (New Position) |
Filing History |
| 2021-02-12 06:07 am Purchase |
2010-02-28 | 13G | PMV Pharmaceuticals, Inc. PMVP |
INTERWEST PARTNERS X LP | 6,469,911 14.500% |
6,469,911 (New Position) |
Filing History |
| 2020-10-05 5:23 pm Purchase |
2020-09-25 | 13D | PMV Pharmaceuticals, Inc. PMVP |
ORBIMED ADVISORS LLC | 6,589,330 14.700% |
6,589,330 (New Position) |
Filing History |
| 2020-10-05 5:04 pm Purchase |
2020-09-25 | 13G | PMV Pharmaceuticals, Inc. PMVP |
VIKING GLOBAL INVESTORS LP | 2,641,840 6.100% |
2,641,840 (New Position) |
Filing History |
| 2020-09-30 4:33 pm Purchase |
2020-09-25 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Boxer Capital LLC | 2,268,236 5.100% |
2,268,236 (New Position) |
Filing History |